PACTG P1006: THE EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)

PACTG P1006：高活性抗逆转录病毒治疗 (HAART) 的效果

• 批准号: 7376171
• 负责人: Hans M Spiegel
• 金额: $ 0.14万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7376171
• 关键词: PACTG; P1006; EFFECTS; HIGHLY; ACTIVE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. HIV-1 infected children treated with multiple potent antiretrovirals have experienced a significant increase in CD4 cells after initiation of highly active antiretroviral therapy (HAART). Although researchers are aware there are several changes in the immune function following HAART, no large published studies have delineated the dynamics of immune recovery in HIV-infected ch

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中出现。列出的机构是中心的机构，不一定是研究者的机构。接受多种强效抗逆转录病毒药物治疗的 HIV-1 感染儿童在开始高效抗逆转录病毒治疗 (HAART) 后，CD4 细胞显着增加。尽管研究人员意识到HAART后免疫功能发生了一些变化，但还没有发表的大型研究描述了HIV感染者免疫恢复的动态。